To face the tremendous problem of antibiotic-resistant bacteria, Coris BioConcept has developed a new range of tests under the brand name “RESIST”. Carbapenemase-producing Enterobacteriaceae (CPE) represent a major health concern and any diagnostic tool helping their detection in the laboratory could improve patient safety. A first test (OXA-48 K-SeT) has been launched last March for the detection of OXA-48-like-producing Enterobacteriacae from culture colonies. After this very successful launch supported by two oral presentations during ECCMID in Copenhagen, a second product is now available for the detection of KPC (Klebsiella pneumoniae carbapenemase) belonging to class A carbapenemases. It is the most frequent enzyme of this group and shows the highest spreading activity. This new test, KPC K-SeT, combined with OXA-48 K-SeT will give diagnostic labs the possibility to identify within minutes two of the main carbapenemases observed in Europe.